Profile for Canada Patent: 3004028
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Canada Patent: 3004028
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Aug 24, 2026 | Valeant Pharms Intl | GIAZO | balsalazide disodium |
| ⤷ Start Trial | Aug 24, 2026 | Valeant Pharms Intl | GIAZO | balsalazide disodium |
| ⤷ Start Trial | Aug 2, 2026 | Valeant Pharms Intl | GIAZO | balsalazide disodium |
| ⤷ Start Trial | Feb 24, 2027 | Valeant Pharms Intl | COLAZAL | balsalazide disodium |
| ⤷ Start Trial | Feb 24, 2027 | Valeant Pharms Intl | COLAZAL | balsalazide disodium |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
